In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.
The authors explore the health barriers and vulnerabilities of undocumented immigrants during the coronavirus pandemic, reveal the gaps in the Covid-19 relief bills and consider the implications for immigrant children.
Pamela Lizette Cruz, Quianta Moore, Laura ZelayaJuly 7, 2020
The authors examine the varied approaches used by the U.S. and Iran during the ongoing nuclear negotiations, with particular emphasis on how each side approaches the Israeli-Palestinian arena and Iran’s entrenchment in Syria and Lebanon.
The number of energy-related social conflicts in Mexico has risen dramatically over the last several years. The authors review the reasons for these conflicts and the social impact assessments that should be required for firms developing energy projects in Mexico.
Ivonne Cruz, Adrian Duhalt, Pamela Lizette CruzJune 21, 2019
Why do unaccompanied minors flee their home countries and what happens when they reach Mexico or the United States? This report provides an overview of the perilous journey and the reality of detention centers, concluding that a child-centric approach in both countries should address the needs of these children.
The director of the White House Office of Science and Technology Policy (OSTP) plays a central role in advising the president on the impact of science and technology on domestic and global affairs, and on federal funding of scientific research. This paper provides recommendations for the next president to consider when choosing a science advisor and establishing science and technology policy priorities. The project also offers guidance to the next science advisor for developing effective policy while serving in the White House. The recommendations are based on lessons learned from past presidential science advisors as well as feedback from more than 60 reviewers, including individuals who currently serve or have served the OSTP, the President’s Council of Advisors for Science and Technology, federal agencies, Congress or congressional staff, and nongovernmental organizations as well as policy scholars.
Neal F. Lane, Kirstin R.W. Matthews, Kenneth M. EvansSeptember 12, 2016
State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.
Baker Institute Policy Report #64 highlights some of the central ethical issues pertaining to NTD policy development and argues that ethical considerations should be included in the policy development process.
Kirstin R.W. Matthews, Ana S. IltisFebruary 29, 2016
Baker Institute Policy Report #65 summarizes the key findings of the Baker Institute conference "The United States and Mexico: Addressing a Shared Legacy of Neglected Tropical Diseases and Poverty."
Jennifer R. Herricks, Kirstin R.W. Matthews, Peter J. HotezFebruary 15, 2016
This report describes the problems associated with unproven stem cell treatments, focusing on those without FDA approval undertaken by NFL players in the past five years.